Post-translational Modification of α-Synuclein Modifies Monomer Dynamics and Aggregation Kinetics
Kasun GamageiD, Binyou WangiD, Eldon R. HardiD, Thong Van, Ana GalesiciD, George R. Phillips, Matthew R. PrattiD, Lisa J. LapidusiD
Abstract
The intrinsically disordered protein -Synuclein is identified as a major toxic aggregate in Parkinsons as well as several other neurodegenerative diseases. Recent work on this protein has focused on the effects of posttranslational modifications on aggregation kinetics. Among these, O-GlcNAcylation of -Synuclein has been observed to inhibit the aggregation propensity of the protein. Here we investigate the monomer dynamics of two O-GlcNAcylated -Synucleins, -Syn(gT72) and -Syn(gS87) and correlate them with the aggregation kinetics. We find that, compared to the unmodified protein, glycosylation at T72 makes the protein less compact and more diffusive while glycosylation at S87 makes the protein more compact and less diffusive. Based on a model of the earliest steps in aggregation, we predict that T72 should aggregate slower than unmodified protein, which is confirmed by ThT fluorescence measurements. In contrast, S87 should aggregate faster, which is not mirrored in ThT kinetics of later fibril formation but does not rule out a higher rate of formation of small oligomers. Together, these results show that posttranslational modifications do not uniformly affect aggregation propensity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 11
- FWCI
- 2.75
- Field percentile
- top 9%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Glycation renders alpha-synuclein oligomeric strain and modulates microglia activation
Manisha Kumari, Bhoj Kumar, … Tushar Kanti Maiti·bioRxiv·Jan 15, 2022
- Phosphorylation and O-GlcNAcylation at the same alpha-synuclein site generate distinct fibril structures
- N-terminal acetylation reduces α-synuclein pathology in models of Parkinson's disease
Esther del Cid‐Pellitero, Thomas Goiran, … Edward A. Fon·Neurobiology of DiseasePeer-reviewed·Jun 11, 2026
- Local ionic conditions modulate the aggregation propensity and influence the structural polymorphism of alpha-synuclein
Maria Zacharopoulou, Neeleema Seetaloo, … Gabriele S. Kaminski Schierle·Journal of the American Chemical SocietyPeer-reviewed·Apr 10, 2025
- Glycated alpha-synuclein assemblies cause distinct Parkinsons disease pathogenesis in mice
Akshaya Rajan, Anish Varghese, … Poonam Singh Thakur·ACS Chemical NeurosciencePeer-reviewed·Sep 12, 2025
- O-GlcNAc modification forces the formation of an α-Synuclein amyloid-strain with notably diminished seeding activity and pathology
A. T. Balana, A.-L. Mahul-Mellier, … M. R. Pratt·bioRxiv·Mar 7, 2023